Hyster-Yale reported solid execution against strong comparables with revenue increasing by 2% year-over-year to $1.0 billion, although operating profit decreased by 44% to $33.1 million and net income decreased by 52% to $17.2 million.
Revenue increased year-over-year, but net income decreased.
Financial leverage improved with debt to total capital down 1,500 Bps vs. prior year and down 500 Bps vs. Q2 2024.
Bookings/backlog stabilized with $370M unit bookings value down 3% vs. Q2 2024 and $2.3B unit backlog value providing ~7-month production foundation.
Company expects inventory decrease & substantial increase in cash flow from operations for FY 2024.
Hyster-Yale provided an outlook for Q4 2024 and FY 2025.
Analyze how earnings announcements historically affect stock price performance